|

This section will
feature a weekly report which generated a lot of interest when it was first
featured on the Medical Breakthroughs site. Come back weekly to read each
highlight as we "Play It Again!"
Antibiotics for Autism #1668
Television News Service/Medical Breakthroughs
©Ivanhoe Broadcast News, Inc. December 2000
(Ivanhoe Newswire) -- According to the National
Institute of Mental Health, about 1 in every 500 people has autism -- a
developmental disorder that affects language and social skills. For years
it's been largely untreatable, but a new study indicates antibiotics may
hold an answer.
Eight-year-old Andrew
Bolte reads at a first-grade level. Sitting with his tutor, he pays close
attention. However his mother, Ellen, says it wasn't always this easy.
"He couldn't stand
to be touched or held. He hated the feeling of clothing on his body,"
she says.
Andrew was diagnosed
with autism when he was 2. Wondering why her son also had chronic diarrhea,
Ellen did her own research and came up with a theory.
Ellen explains, "We
need to look at the gastrointestinal track. There is a connection between
the gut and the brain."
She wondered if a
harmful bacterium in the intestine could be affecting Andrew's brain.
A study by Richard Sandler, M.D., a pediatric
gastroenterologist at Rush-Presbyterian St. Luke's Medical Center in
Chicago, showed she could be right. He treated 11 autistic children with
the antibiotic vancomycin (Vancoled®, Vancocin®) and 9 out of the 11
improved.
Dr. Sandler explains,
"They got calmer, could start to pay attention, and could start to
follow directions."
However over time,
nearly all of the children had some relapse.
Dr. Sandler says,
"Vancomycin is not a treatment for the kids. It's just a lead. A very
important one, I think, but just a lead."
It's a lead indicating
that antibiotics may one day play a role in a cure for Andrew and thousands
of others who suffer from autism.
Ellen says, "Somebody has got to keep pushing this
forward, and for some reason, God gave me the strength to keep doing it. So
that is what I will keep doing."
Dr. Sandler says about
25 percent of children with autism experience chronic diarrhea or
constipation. Further research is now underway to determine if, in fact, a
bug or toxin is present in autistic patients' intestinal tracts.
If you would like
more information, please contact:
Ellen
Bolte, Study Co-Coordinator
Section of Pediatric Gastroenterology
Rush-Presbyterian St. Luke's Medical Center
1725 West Harrison, Suite 946
Chicago, Illinois 60612
(312) 563-2103
Antibiotics for Autism Research Summary
Television News Service/Medical Breakthroughs
©Ivanhoe Broadcast News, Inc. December 2000
BACKGROUND: Autism affects approximately five in every 10,000 children. It is a
developmental disorder that often involves the loss of language, social and
play skills. Autism is four times more prevalent in boys than girls and
knows no racial, ethnic, or social boundaries. According to researchers,
autism manifests during early infancy with impairment typically persisting
into adulthood. Autism has been largely untreated by the medical community
even though it is the third most commonly diagnosed childhood disorder. Symptoms
can include:
·
Unresponsiveness
to people
·
Lack
of attachment to parents or caretakers
·
Rigid
or flaccid muscle tone while being held
·
Little
or no interest in human contact
·
Lack
of attachment to parents or caretakers
·
Language
impairment
·
Seemingly
meaningless repetition of words or phrases
·
Self-destructive
behavior
·
Distressed
by minor changes in the environment
·
Delayed
mental and social skills
·
Over-reaction
or under-reaction to sensory stimulus
·
Aggressive
behavior patterns such as uncontrollable head banging, screaming fits and
arm flapping
BATTLING BACTERIA: Researchers at Rush-Presbyterian St. Luke's Medical
Center have found that some children suffering from autism may experience
short-term, but dramatic, improvement after being treated with antibiotics.
During a two-year study, patients whose autism involves bacterial
colonization in the bowel were treated with the antibiotic vancomycin
(Vancoled®, Vancocin®). Nine out of eleven children treated experienced
improved behavior, social skills and cognitive function. While the
improvement was at times impressive, some regression occurred in 10 of the
11 children. Some children's skills returned to what they were prior to
treatment. Researchers emphasize vancomycin is not recommended for general
use because it would encourage further development of resistance to certain
bacteria. However, this study is important because it indicates that
further research into a possible connection between intestinal bacteria and
autism is warranted.
FUTURE STUDIES: Researchers are now trying to locate a specific toxin or bacteria
that may be present in the bowel of children with autism. They say that if
this can be accomplished, they will be able to better determine a possible
mode of treatment. Doctors say future treatments may include an antibiotic
or perhaps a combination of antibiotics, but it is too soon to tell.
Researchers say future studies should address whether there are better
drugs for this treatment, how long therapy should be continued, and what can
be done to prevent relapse once treatment is stopped.
If you would like more information, please contact:
Ellen
Bolte, Study Co-Coordinator
Section of Pediatric Gastroenterology
Rush-Presbyterian St. Luke's Medical Center
1725 West Harrison, Suite 946
Chicago, Illinois 60612
(312) 563-2103
Prior Reports:
Curbing
Autistic Aggression December 2000
Overcoming
Autism March 1998
Autism/Manic
Depression December 1996
Electronic
Ear November 1996
Birthday
Revelations of Autism July 1996
Click
here to order
additional research and full-length news video.
|